# COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

> **NCT06704516** · PHASE1 · RECRUITING · sponsor: **University of Oxford** · enrollment: 10 (estimated)

## Conditions studied

- Menopause
- Metabolic Dysfunction Associated Steatotic Liver Disease

## Interventions

- **DRUG:** Menopausal hormone therapy

## Key facts

- **NCT ID:** NCT06704516
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2025-08-05
- **Final completion:** 2026-01-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06704516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06704516, "COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06704516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*